| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| ACCOUNTING FEES | 3,225 | 3,225 | 0 | 0 |
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| INVESTMENT IN GOLDMAN SACHS - 15867 | 30,325 | 20,694 |
| INVESTMENT IN APPLIED STEMCELL INC | 52,500 | 52,500 |
| INVESTMENT IN EPITOMICS INC | 322,500 | 322,500 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| LEGAL FEES | 2,000 | 0 | 0 | 2,000 |
| Description | Amount |
|---|---|
| BOOK/TAX DIFFERENCE ON SALE OF WUXI PHARMATECH INC | 703,168 |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| FILING FEES | 850 | 0 | 0 | 850 |